Skip to main content
. 2017 Nov 9;2017(11):CD011770. doi: 10.1002/14651858.CD011770.pub2

Dar 2013.

Methods Parallel group RCT.
Participants In India, 80 ASA class I‐II participants aged 20‐50 years undergoing upper limb surgery with supraclavicular brachial plexus block were included. No exclusion criteria were stated.
Interventions Block
All participants received supraclavicular brachial plexus block with ropivacaine 0.5% 30 ml using landmarks.
Dexamethasone/placebo
Dexamethasone group: dexamethasone 8 mg perineurally.
Placebo group: normal saline 2 ml perineurally.
Intraoperative anaesthesia/analgesia
None described.
Postoperative analgesia
Diclofenac IM 75 mg was administered when the VAS was greater than 4.
Outcomes Outcomes of interest for the review
Duration of sensory block defined as the time interval between the end of local anaesthetic administration and complete resolution of sensory block (normal sensation).
Duration of motor block defined as the time interval between the end of local anaesthetic administration and the recovery of full power in the relevant muscle group.
Incidence of adverse events including hypotension (a 20% decrease in relation to baseline), bradycardia (heart rate less than 50 beats per minute), hypoxaemia (SpO2 < 90%) and nausea and vomiting.
Other outcomes
Onset of sensory block defined as the time interval between the end of local anaesthetic administration and complete sensory block.
Onset of motor block defined as the time interval between the end of local anaesthetic administration and the time of no movement in the relevant group.
Quality of intraoperative analgesia judged by the investigator on a 4‐point scale.
Notes Funding: none.
Conflicts of interest: none.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk No indication of how random sequence was generated.
Allocation concealment (selection bias) Low risk Sealed envelopes were used to conceal treatment allocation.
Blinding of participants (detection bias) Unclear risk No indication whether participants were blinded.
Blinding of personnel (detection bias) Unclear risk No indication whether personnel were blinded.
Blinding of outcome assessment (detection bias) 
 All outcomes Unclear risk No indication whether outcome assessors were blinded.
Incomplete outcome data (attrition bias) 
 All outcomes Low risk No missing outcome data.
Selective reporting (reporting bias) Low risk No protocol available. All outcomes reported as described in the methods section.
Other bias Low risk Appears to be free of any other bias.